Following a prolonged multi-year valuation reset across 2023–2025, the United Kingdom healthcare technology M&A market has entered a highly disciplined, execution-led deal cycle. Driven by structural shifts in healthcare delivery, persistent labour constraints in public health systems, and corporate patent cliffs facing large biopharmaceutical entities, global deal flow is accelerating, with international buyers turning to the UK as a primary incubator for regulatory-cleared,

FemTech startup Daye has been announced as the winner of the Digital Health Rewired Pitchfest 2026 competition following the live final held at Rewired 2026 at the NEC, Birmingham.